HOME >> MEDICINE >> NEWS
Dental Researchers Retract Statement Indicating Hydrogen Peroxide May Be Cancer,,Promoter

BUFFALO, N.Y. -- Authors of an abstract reporting preliminary results showing hydrogen peroxide may be a cancer promoter have retracted their presentation of study findings.

The study was conducted in the Department of Oral and Maxillofacial Surgery in the University at Buffalo School of Dental Medicine.

An abstract was published in conjunction with the joint meeting of the American Association of Dental Research and the International Association of Dental Research held March 10-13 in Vancouver, British Columbia, and a poster relating to the study was presented at the meeting.

The retraction states:

"As authors on the abstract 'Hydrogen Peroxide: A Promoter in Cancer Development,' presented on March 12, 1999, at the combined meetings of the American and International Associations of Dental Research, we are retracting the presentation of study findings. Data obtained in that study were mistakenly interpreted as being suggestive of a link between the use of hydrogen peroxide or hydrogen peroxide-containing pharmaceuticals and oral precancerous lesions or frank cancerous lesions in humans.

"Briefly, this study utilized the hamster buccal-cheek-pouch model, and consisted of painting cheek pouches of the animals bilaterally with DMBA (0.5%9, 10-dimethyl-1, 2-benzantracene), a known carcinogen, for a period of six weeks, which ordinarily produces visible lesions that are characteristically premalignant. There were no macroscopically obvious visible lesions present at that time.

"Following the induction phase, the DMBA paintings were discontinued. After a period of one week, the right cheek pouches were treated three times weekly with 3 percent hydrogen peroxide only for a period of 12 weeks.

"Using a parenterally-administered fluorescence-producing substance and a photodetection device, fluorescence readings were obtained from the left cheek pouches and compared to those
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-2626
University at Buffalo
18-Mar-1999


Page: 1 2

Related medicine news :

1. Dental erosion
2. Dental practitioners can be instrumental in preventing their patients eating disorders
3. 2005 Research in Dental Caries Award
4. Awards & fellowships at the International & American Association for Dental Research General Session
5. Lectures, keynoters, symposia highlight International Dental Research meeting
6. Strokes: Dental x-rays reveal more than cavities
7. Dental x-rays could be first step in osteoporosis screening
8. Dental pulp cells may hold key to treatment of Parkinsons disease
9. Dental disease hits hardest among older blacks
10. Dental X-rays during pregnancy associated with low birth weight babies
11. Dental X-rays of pregnant women associated with low-weight babies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... December 06, 2019 , ... Connecticut is home ... excellence in patient care. On December 12th, Hartford Business Journal will recognize eight ... Care Heroes Awards at the Hartford Marriott. , “We are fortunate to have ...
(Date:12/6/2019)... ... December 06, 2019 , ... Brain ... in Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals of Quantitative ... Understand methods of quantitative sEMG analysis during ictal events;, 2. Review specific sEMG ...
(Date:12/5/2019)... Conn. (PRWEB) , ... December 05, 2019 , ... ... Physician Practice M&A: Risks and Rewards of Building Platforms— on Thursday, December 12, ... are competing for large, multi-specialty medical groups. Middle-market PE firms are scrambling to ...
(Date:12/4/2019)... ... December 04, 2019 , ... Now ... provides protection from disruptions to cells and tissue and inflammation that leads to ... Lag, is available in a dietary supplement product called Prepair™ . , ...
(Date:12/4/2019)... ... December 04, 2019 , ... Eolas Therapeutics Inc. today ... use and dependence. The study will investigate safety and pharmacokinetics (PK) of AZD4041 ... orexin-1 (hypocretin-1) receptors that is being developed in collaboration with AstraZeneca. , “Smoking-related ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... In ... this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures are designed ... requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients from the ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... distribution agreement with Forbidden Fruit Garden Supply LLC (a division of Horticultural Holdings ... discerning clientele of professional growers. , FFGS is a team of disciplined ...
(Date:12/4/2019)... ... 2019 , ... The Harm Reduction Institute (HRI) as a part of the ... rehab center and non-profit Intensive outpatient after care (IOP) , has officially ... distributed Naloxone amongst members of the own community in Orange County, CA. , ...
Breaking Medicine Technology:
Cached News: